Wealthstreet Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$4K Hold
17
0.11% 65
2021
Q4
$4K Hold
17
0.1% 65
2021
Q3
$4K Hold
17
0.11% 65
2021
Q2
$4K Sell
17
-89,223
-100% -$21.9M 0.02% 90
2021
Q1
$22.2M Sell
89,240
-871
-1% -$208K 2.17% 7
2020
Q4
$20.7M Sell
90,111
-825
-0.9% -$190K 2.1% 6
2020
Q3
$23.1M Buy
90,936
+1,120
+1% +$277K 2.58% 5
2020
Q2
$21.2M Sell
89,816
-200
-0.2% -$45.6K 2.59% 5
2020
Q1
$18.2M Sell
90,016
-1,350
-1% -$295K 2.7% 4
2019
Q4
$22M Sell
91,366
-35
-0% -$7.71K 2.57% 4
2019
Q3
$19.1M Sell
91,401
-3,103
-3% -$596K 2.44% 5
2019
Q2
$17.4M Buy
94,504
+1,600
+2% +$286K 2.25% 6
2019
Q1
$17.6M Sell
92,904
-3,283
-3% -$627K 2.33% 7
2018
Q4
$18.5M Sell
96,187
-1,527
-2% -$298K 2.59% 6
2018
Q3
$20.3M Sell
97,714
-545
-0.6% -$107K 2.5% 5
2018
Q2
$18.1M Sell
98,259
-21,272
-18% -$3.76M 2.4% 6
2018
Q1
$20.4M Sell
119,531
-205
-0.2% -$37.6K 2.56% 5
2017
Q4
$20.8M Buy
+119,736
New +$21.2M 2.52% 5

Other funds holding AMGN

Wealthstreet Investment Advisors's AMGN Position: Q1 2022 in Review

Wealthstreet Investment Advisors held its Amgen (AMGN) position steady in Q1 2022 at 17 shares worth $4K. The position accounts for 0.11% of the portfolio, ranked #65.

Wealthstreet Investment Advisors first reported a position in AMGN in Q4 2017 and has held it in 18 quarters since. The position peaked at $23.1M in Q3 2020. 2,336 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Wealthstreet Investment Advisors held 17 shares of Amgen worth $4K as of Q1 2022.
  • Wealthstreet Investment Advisors left its Amgen share count unchanged in Q1 2022.
  • Amgen made up 0.11% of Wealthstreet Investment Advisors's portfolio in Q1 2022, its #65 holding.
  • Wealthstreet Investment Advisors first reported a position in Amgen in Q4 2017 and has held it in 18 quarters since.
  • Wealthstreet Investment Advisors's Amgen position peaked at $23.1M in Q3 2020.
  • 2,336 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Wealthstreet Investment Advisors's 13F filing for Q1 2022, filed 25 Apr 2022.